Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
By inhibiting the DPP-4 enzyme, DPP-4 inhibitors slows their inactivation, thereby increasing the levels of GLP-1 and GIP, which in turn lower plasma glucose levels
(Study: Blonde et al., 2017) Cardiovascular Benefits: Beyond weight loss, both drugs have shown significant cardiovascular advantages, reducing the risk of heart-related complications in individuals with obesity and associated comorbidities
The manufacturers website lists various savings options
In rare cases, you may experience more severe side effects such as: Allergic reactions Hypoglycemia (low blood sugar) Diabetic retinopathy complications Inflammation of the pancreas (pancreatitis) Gallbladder or kidney disease Some studies have also shown that GLP-1 medications may increase your risk of developing thyroid tumors and endocrine system disorders
Insurance companies definitely dont cover the cost for the merely overweight
US$ 20.64
US$ 22.06
US$ 25.93
US$ 20.80
